Onco-Innovations Limited (NEO:ONCO)
Canada · Delayed Price · Currency is CAD 1.650
-0.070 (-4.07%)
Nov 7, 2025, 4:00 PM EST
Onco-Innovations Company Description
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.
The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology.
Onco-Innovations Limited is headquartered in Calgary, Canada.
Onco-Innovations Limited
| Country | Canada |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 1 |
| CEO | Thomas O’Shaughnessy |
Contact Details
Address: 7th Street SW Calgary, British Columbia T2R 1A5 Canada | |
| Phone | 848-488-9277 |
| Website | oncoinnovations.com |
Stock Details
| Ticker Symbol | ONCO |
| Exchange | Cboe Canada |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Thomas O’Shaughnessy | Chief Executive Officer |
| Nico Mah | Chief Financial Officer |